Shanshan Jiang

ORCID: 0000-0003-3461-6076
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoplatforms for cancer theranostics
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Advanced Nanomaterials in Catalysis
  • Photoacoustic and Ultrasonic Imaging
  • Extracellular vesicles in disease
  • Lung Cancer Diagnosis and Treatment
  • Nanoparticle-Based Drug Delivery
  • Inflammatory Biomarkers in Disease Prognosis
  • Photodynamic Therapy Research Studies
  • Epigenetics and DNA Methylation
  • Helicobacter pylori-related gastroenterology studies
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Autophagy in Disease and Therapy
  • Cancer, Lipids, and Metabolism
  • Cancer Mechanisms and Therapy
  • Advanced biosensing and bioanalysis techniques
  • Colorectal Cancer Treatments and Studies
  • Cancer-related gene regulation
  • Ferroptosis and cancer prognosis
  • Transplantation: Methods and Outcomes
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Luminescence and Fluorescent Materials
  • Histone Deacetylase Inhibitors Research

Shenzhen University
2018-2025

Yantai Institute of Coastal Zone Research
2024-2025

University of Chinese Academy of Sciences
2025

Fudan University Shanghai Cancer Center
2022-2024

Shanghai Medical College of Fudan University
2022-2024

Jiangxi Provincial People's Hospital
2024

Shenzhen University Health Science Center
2019-2024

Union Hospital
2024

Huazhong University of Science and Technology
2024

State Key Laboratory of Information Engineering in Surveying Mapping and Remote Sensing
2024

Glucose oxidase (GOx) has been recognized as a "star" enzyme catalyst involved in cancer treatment the past few years. Herein, GOx is mineralized with manganese-doped calcium phosphate (MnCaP) to form spherical nanoparticles (GOx-MnCaP NPs) by an situ biomimetic mineralization method, followed loading of doxorubicin (DOX) construct biodegradable, biocompatible, and tumor acidity-responsive nanotheranostics for magnetic resonance imaging (MRI) cascade reaction-enhanced cooperative treatment....

10.1021/acsnano.9b05836 article EN ACS Nano 2019-12-13

Colitis-associated colorectal cancer (CAC), in which chronic inflammation is a well-recognized carcinogen, requires concurrent anti-inflammation and antitumor treatments the clinic. Herein, we report polyethylene glycol (PEG)-coated (PEGylated) ultrasmall rhodium nanodots (Rh-PEG NDs) can serve as metallic nanozyme with reactive oxygen nitrogen species (RONS) scavenging properties well photothermal activities for theranostics colon diseases. Benefiting from multienzyme against RONS, Rh-PEG...

10.1021/acs.nanolett.9b05035 article EN Nano Letters 2020-04-29

Companion diagnostics (CDx) provides critical information for precision medicine. However, current CDx is mostly limited to in vitro tests, which cannot accurately evaluate the disease progression and treatment response real time. To overcome this challenge, herein a glucose oxidase (GOx)-engineered conjugated polymer (polyaniline, PANI) nanoplatform (denoted as PANITG) reported activatable imaging-based multistage augmented photothermal/starvation synergistic therapy. PANITG comprises...

10.1002/adma.202200062 article EN Advanced Materials 2022-03-04

Abstract The development of semiconducting polymers (SPs) with simultaneous second near‐infrared (NIR‐II) absorption and multimodal phototheranostic functions is highly desired in the field oncotherapy. Aggregation‐induced emission luminogens (AIEgens) have been acknowledged to possess unique potential integrating multiple diagnostic therapeutic modalities into one organic molecule. Nevertheless, SPs are hard achieve AIE activity due their extended π‐conjugated skeletons as well large planar...

10.1002/adfm.202401627 article EN Advanced Functional Materials 2024-03-22

To design a clinically translatable nanomedicine for photodynamic theranostics, the ingredients should be carefully considered. A high content of nanocarriers may cause extra toxicity in metabolism, and multiple theranostic agents would complicate preparation process. These issues less concern if nanocarrier itself has most functions. In this work, poly(ethylene glycol)-boron dipyrromethene amphiphile (PEG-F54 -BODIPY) with 54 fluorine-19 (19 F) is synthesized employed to emulsify...

10.1002/adma.201806444 article EN Advanced Materials 2019-03-25

Inspired by the chain reactions among silver nanoparticles, glucose oxidase (GOx) and intratumoral glucose, a degradable silver-based nanoplatform was developed for synergistic cancer starving-like/metal ion therapy.

10.1039/c8mh00908b article EN Materials Horizons 2018-10-23

Abstract Tumor‐microenvironment‐responsive theranostics have great potential for precision diagnosis and effective treatment of cancer. Polyaniline (PANI) is the first reported pH‐responsive organic photothermal agent widely used as a theranostic agent. However, tumor PANI‐based agents are not explored, mainly because conversion from emeraldine base (EB) to salt (ES) state PANI requires pH < 4, which lower than acidic microenvironment. Herein, designed prepared amplified photoacoustic...

10.1002/smll.201902926 article EN Small 2019-08-25

Carbapenem-resistant organisms (CRO) have emerged as a significant worldwide issue. However, the availability of efficacious antibiotics for treating CRO infections remains limited. Polymyxins, including colistin sulfate, represent last-line therapeutic option against infections. This study aims to retrospectively evaluate clinical effectiveness and safety sulfate in managing among patients with hematological diseases. Between April 2022 January 2023, total 118 diagnosed infection were...

10.1007/s40121-023-00909-8 article EN cc-by-nc Infectious Diseases and Therapy 2024-01-01

Alkaline phosphatase (ALP) is distributed widely in living organisms and an important biomarker closely related to many physiological pathological processes. However, vivo real-time detection of ALP remains a significant challenge. Herein, we developed turn-on molecular probe (denoted as LET-3) visualize activity tumor tissues through near-infrared fluorescence (NIRF) photoacoustic (PA) dual-modal imaging. LET-3, composed NIR hemicyanine dye (LET-CyOH) phosphate moiety, showed 23-fold NIRF...

10.1021/acs.analchem.9b00109 article EN Analytical Chemistry 2019-05-15

Abstract The delivery of glucose oxidase (GOx) requires extra carriers, which suffers from early leakage and exposure GOx. These issues will be less concern if GOx itself acts as a drug carrier. However, the catalytic activity in blood still needs to inhibited. Herein, we found that could self‐assemble with hydrophobic molecules into uniform stable nanoparticles (NPs), including sorafenib, 4′‐(amino‐methyl phenyl)‐2,2′ : 6′,2′′‐terpyridine modified cyanin paclitaxel. NPs was significantly...

10.1002/anie.202208583 article EN Angewandte Chemie International Edition 2022-07-18

Biopsy samples were taken from the gastric mucosa of 209 patients endoscoped for dyspepsia symptoms. Campylobacter-like organisms (CLOs) cultured 74 179 (41.4%) cases and seen in sections 110 (52.6%) smears 119 (56.9%) cases; totally, 145 positive, giving a rate 69.4%. CLOs positive 45 57 (78.9%) with superficial gastritis, 52 64 (81.3%) atrophic 18 21 (85.7%) ulcer, 12 14 duodenal 8 10 (80.0%) stump whereas only few found 3 15 (20.0%) histologically normal subjects 7 28 (25.0%) carcinoma....

10.3109/00365528708991897 article EN Scandinavian Journal of Gastroenterology 1987-01-01

Annexin A3 (ANXA3) has been found to play important roles in cancer progression, metastasis, and drug resistance; however, its role hepatocellular carcinoma (HCC) remains unknown. In this study, we investigated the expression level, clinical significance biologic function of ANXA3 HCC. Real-time quantitative reverse transcriptase-polymerase chain reaction, western blotting immunohistochemical staining were used examine levels HCC tumor tissue, correlation with clinicopathological features...

10.1002/mc.22126 article EN Molecular Carcinogenesis 2013-12-23

Abstract Afatinib, a second-generation tyrosine kinase inhibitor (TKI), has been approved for the treatment of advanced EGFR -mutant non-small cell lung cancer (NSCLC). However, afatinib’s clinical application is still hampered by acquired resistance. Recently, autophagy considered as an important mechanism resistance to TKI. Herein, we investigated induction well its influence on anti-lung adenocarcinoma activity afatinib in two activating -mutants H1975 and H1650 cells. First, Growth...

10.1038/s41598-017-04258-8 article EN cc-by Scientific Reports 2017-06-27
Coming Soon ...